Management of New Onset Diabetes: Time to Change Therapeutic Strategies

Usama A Sharaf El-Din,M. Salem,D. Abdulazim

Published 2019 in Unknown venue

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2019
Venue
Unknown venue
Publication date
Unknown publication date
Fields of study
Not labeled
Identifiers
No identifiers available.
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.
2019cited by this paper
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
2019cited by this paper
Clinical Credence - SGLT2 Inhibitors, Diabetes, and Chronic Kidney Disease.
2019cited by this paper
AACE/ACE Consensus Statement CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2018 EXECUTIVE SUMMARY
2018cited by this paper
Comparisons of diabetic retinopathy events associated with glucose‐lowering drugs in patients with type 2 diabetes mellitus: A network meta‐analysis
2018cited by this paper
Role of the sodium‐hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes
2018cited by this paper
Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential
2018cited by this paper
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018cited by this paper
Association and biomarker potential of elevated serum adiponectin with nephropathy among type 1 and type 2 diabetics: A meta-analysis
2018cited by this paper
Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines
2018cited by this paper
Clinical Significance of Hemostatic Parameters in the Prediction for Type 2 Diabetes Mellitus and Diabetic Nephropathy
2018cited by this paper
Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects.
2017cited by this paper
Complement Activation in Patients With Diabetic Nephropathy
2017cited by this paper
The role of NADPH oxidases in diabetic cardiomyopathy.
2017cited by this paper
Activation of Nrf2 signaling by natural products-can it alleviate diabetes?
2017cited by this paper
Resveratrol Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Patients With Type 2 Diabetes Mellitus.
2017cited by this paper
Effects of Once‐Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
2017cited by this paper
SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome.
2017cited by this paper
The cardiovascular benefits of empagliflozin: SGLT2-dependent and -independent effects
2017cited by this paper
Diabetes, hypertension, and chronic kidney disease progression: role of DPP4.
2017cited by this paper
Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+/H+ exchanger, lowering of cytosolic Na+ and vasodilation
2017cited by this paper
The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes.
2017cited by this paper
Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA‐T2D trial
2017cited by this paper
Uric Acid Induces Endothelial Dysfunction by Activating the HMGB1/RAGE Signaling Pathway
2017cited by this paper
Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial.
2016cited by this paper
Internal Pudental Artery Dysfunction in Diabetes Mellitus Is Mediated by NOX1-Derived ROS-, Nrf2-, and Rho Kinase–Dependent Mechanisms
2016cited by this paper
Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules
2016influential reference
Cut to the chase: a review of CD26/dipeptidyl peptidase‐4's (DPP4) entanglement in the immune system
2016influential reference
Neurovascular Protective Function of Endothelial Nitric Oxide　- Recent Advances.
2016cited by this paper
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
2016cited by this paper
Serum Uric Acid as a Risk Factor for Chronic Kidney Disease in a Japanese Community　- The Hisayama Study.
2016influential reference
Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation
2016cited by this paper
The Cardiovascular Biology of Glucagon-like Peptide-1.
2016cited by this paper
Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial.
2016cited by this paper
Hypoxia Alters the Expression of Dipeptidyl Peptidase 4 and Induces Developmental Remodeling of Human Preadipocytes
2016cited by this paper
Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice
2016cited by this paper
Mannose‐Binding Lectin and Diabetic Nephropathy in Type 1 Diabetes
2016cited by this paper
PROTECTIVE EFFECTS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS ON PROGRESSION OF DIABETIC RETINOPATHY IN PATIENTS WITH TYPE 2 DIABETES
2016cited by this paper
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
2016cited by this paper
Sinomenine alleviates high glucose-induced renal glomerular endothelial hyperpermeability by inhibiting the activation of RhoA/ROCK signaling pathway.
2016cited by this paper
Acute Resveratrol Consumption Improves Neurovascular Coupling Capacity in Adults with Type 2 Diabetes Mellitus
2016cited by this paper
Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes☆,☆☆
2016cited by this paper
DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury
2016cited by this paper
Momordica charantia polysaccharides mitigate the progression of STZ induced diabetic nephropathy in rats.
2016cited by this paper
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
2016cited by this paper
Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS
2016influential reference
Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
2016influential reference
Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events
2016cited by this paper
Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus.
2016cited by this paper
Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
2016cited by this paper
Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
2016cited by this paper
Uric Acid Is Independently Associated with Diabetic Kidney Disease: A Cross-Sectional Study in a Chinese Population
2015cited by this paper
Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis
2015cited by this paper
Elevated Serum Levels of Mannose-Binding Lectin and Diabetic Nephropathy in Type 2 Diabetes
2015cited by this paper
Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.
2015cited by this paper
New Insights for Oxidative Stress and Diabetes Mellitus
2015cited by this paper
Renal Oxidative Stress Induced by Long-Term Hyperuricemia Alters Mitochondrial Function and Maintains Systemic Hypertension
2015cited by this paper
High Mannose-Binding Lectin Serum Levels Are Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes
2015cited by this paper
Fructose and uric acid in diabetic nephropathy
2015cited by this paper
Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice.
2015cited by this paper
Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3‐year randomized parallel‐controlled study
2015cited by this paper
Are reactive oxygen species still the basis for diabetic complications?
2015cited by this paper
Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis
2015cited by this paper
Increased serum mannose binding lectin levels are associated with diabetic retinopathy.
2015cited by this paper
Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus
2015cited by this paper
Serum Uric Acid and Risk of CKD in Type 2 Diabetes.
2015influential reference
Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy.
2015cited by this paper
Na(+)/H(+) exchanger in the regulation of platelet activation and paradoxical effects of cariporide.
2015cited by this paper
Curbing the Diabetes Pandemic: The Need for Global Policy Solutions.
2015cited by this paper
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
2015cited by this paper
Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies
2014cited by this paper
Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial
2014cited by this paper
The Nrf 2 pathway in the progression of renal disease
2014cited by this paper
SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
2014cited by this paper
The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?
2014cited by this paper
Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type 2 Diabetes.
2014cited by this paper
Uric acid‐dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids
2014cited by this paper
Evaluation of the Effect of Curcumin Capsules on Glyburide Therapy in Patients with Type‐2 Diabetes Mellitus
2014cited by this paper
Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure.
2014cited by this paper
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
2014cited by this paper
The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors.
2014cited by this paper
Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up‐regulated by hypoxia in human adipocytes and smooth muscle cells
2014cited by this paper
Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy.
2014cited by this paper
Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes.
2014cited by this paper
Linagliptin-Mediated DPP-4 Inhibition Ameliorates Kidney Fibrosis in Streptozotocin-Induced Diabetic Mice by Inhibiting Endothelial-to-Mesenchymal Transition in a Therapeutic Regimen
2014cited by this paper
Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
2014cited by this paper
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014cited by this paper
The endothelium in diabetes: Its role in insulin access and diabetic complications
2013cited by this paper
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
2013cited by this paper
Glucagon-like peptide-1 receptors agonists (GLP1 RA).
2013influential reference
12/15-Lipoxygenase-Derived Lipid Metabolites Induce Retinal Endothelial Cell Barrier Dysfunction: Contribution of NADPH Oxidase
2013cited by this paper
Molecular mechanisms linking diabetes to the accelerated development of atherosclerosis.
2013cited by this paper
Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
2013influential reference
Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction
2013cited by this paper
Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?
2013cited by this paper
Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes
2013cited by this paper
Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial.
2013cited by this paper
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
2013cited by this paper
Protective Effects of Cariporide on Endothelial Dysfunction Induced by Homocysteine
2013cited by this paper
Impact of diabetes mellitus on life expectancy and health-adjusted life expectancy in Canada
2012cited by this paper

CITED BY

No citing papers are available for this paper.